Advanced Search
Your search returned 680 results
  • Mar 29, 2014
    Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA

    MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...

  • Mar 10, 2014
    "Global Heroes" Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October

    MINNEAPOLIS - March 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today applications are open to runners around the world who benefit from medical technology to represent their country on the...

  • Feb 27, 2014
    - U.S. revenue increased 94% in fourth quarter 2013 to $25.9 million, from $13.4 million in fourth quarter of 2012

    HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

  • Feb 19, 2014
    Small, Wireless Monitor Provides Long-Term Remote Monitoring to Help Physicians Diagnose and Monitor Irregular Heartbeats

    MINNEAPOLIS - February 19, 2014 -Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of...

  • Feb 18, 2014
    Revenue of $4.2 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

    MINNEAPOLIS - Feb. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2014, which ended January 24, 2014. The company reported worldwide...

Show 5102550100 per page